BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260610
DTSTAMP:20260514T232812
CREATED:20260211T102827Z
LAST-MODIFIED:20260211T102827Z
UID:42871-1780358400-1781049599@www.pharmajournalist.com
SUMMARY:5th ALS Drug Development Summit
DESCRIPTION:The 5th ALS Drug Development Summit returns to Boston as the ultimate platform honing industry R&D for safer\, more effect and patient-relevant drugs that serve the community\, driving a cure for sporadic and familial ALS. \nWith a brand-new agenda spanning early target exploration through to clinical design\, biomarker strategy\, and regulatory engagement\, attendees will gain comprehensive insights into genetically validated targets\, the evolving biology of TDP 43\, adaptive trial design\, and embedding the patient voice throughout development. \nJoin us for 3 days of unmissable data-driven content\, with 2 tracks spanning discovery to access for the whole team: \nTrack A: Discovery\, Preclinical & Translational – designed for CSOs\, pre-clinical researchers\, discovery scientists\, directors of biology and research\, novel modality scientists\, in viva/in vitro modelling experts and many more\, connect with an intimate group of discovery and preclinical experts for a more discursive session. \nTrack B: Clinical & Regulatory – tailor-made for medical directors\, CMOs\, clinical program leaders\, translational and clinical development heads and clinicians and more; share expertise from diverse clinical challenges and innovation in ALS. \nDesigned for biotech\, pharma\, academia\, and patient advocacy stakeholders\, this unique forum will unite 100+ senior experts and 30+ speakers from companies including AbbVie\, Biogen\, Novartis\, Eli Lilly\, QurAlis\, Prilenia\, Sanofi\, and many more. \nDiscover the full 2026 event guide now to explore all speakers and sessions – https://ter.li/28a6lw
URL:https://www.pharmajournalist.com/event/5th-als-drug-development-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260605
DTSTAMP:20260514T232812
CREATED:20260224T131937Z
LAST-MODIFIED:20260224T132421Z
UID:42974-1780358400-1780617599@www.pharmajournalist.com
SUMMARY:5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit
DESCRIPTION:The 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit returns to Boston in June 2026 as the premier industry forum dedicated to advancing extrahepatic LNP delivery and next-generation targeted lipid nanoparticle technologies. As the field moves beyond liver-focused delivery\, achieving precise\, selective\, tissue-specific targeting remains one of the most critical challenges in genetic medicine. With growing industry validation – including strategic acquisitions by AbbVie and Bristol Myers Squibb – confidence in targeted LNP platforms is accelerating across biopharma. \nOver 3 content-rich days\, 60+ experts from leading biotech\, pharma\, and academia will share cutting-edge data and practical insights on delivering mRNA\, RNA\, gene-editing\, and cell therapy payloads to extrahepatic tissues\, including immune cells\, muscle\, and adipose tissue. Attendees will explore novel targeting ligands\, active and passive targeting strategies\, innovative lipid chemistries\, and advanced formulation approaches designed to improve biodistribution\, potency\, and safety profiles. \nThe summit will also address critical translational challenges\, including targeted LNP analytics\, scalability\, manufacturability\, and immunogenicity – key hurdles in advancing extrahepatic delivery toward clinical success. Through 13+ data-driven case studies\, 6 interactive workshops\, expert panel discussions\, and dedicated networking sessions\, participants will gain actionable strategies to accelerate development timelines and de-risk clinical progression. \nWith representation from pioneering organizations across the delivery ecosystem\, this meeting provides a unique opportunity to benchmark progress\, forge strategic partnerships\, and overcome bottlenecks limiting cell-specific LNP performance. Whether optimizing formulation\, engineering targeting ligands\, refining preclinical models\, or preparing for clinical translation\, this summit delivers the technical depth required to stay at the forefront of innovation. \nVisit Our Website for More Information. \nhttps://ter.li/rt2poz
URL:https://www.pharmajournalist.com/event/5th-extrahepatic-lipid-based-nanoparticles-delivery-summit/
LOCATION:Hotel AKA Boston Common\, 90 Tremont Street\, Boston\, MA\, 02108\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260605
DTSTAMP:20260514T232812
CREATED:20260430T111933Z
LAST-MODIFIED:20260430T111933Z
UID:43436-1780358400-1780617599@www.pharmajournalist.com
SUMMARY:10th R&D Procurement & Sourcing in Pharma Summit
DESCRIPTION:The Future of R&D Procurement Excellence Starts Here! \nThe 10th R&D Procurement & Sourcing in Pharma Summit returns to Boston in June 2026 as the definitive meeting place for procurement\, sourcing and category management leaders across pre‑clinical and clinical R&D. This flagship event is designed to support procurement teams as they transition from transactional buying to strategic\, value‑driven partnership models that accelerate pipeline delivery and protect business continuity. \nBringing together senior R&D procurement leaders from global biopharma\, the summit focuses on strengthening sourcing resilience\, maximising CRO and CMO partnerships\, embedding AI and orchestration tools\, and aligning procurement strategy with scientific and operational ambition across the development lifecycle. \nVisionary Faculty Includes: \n\nNovartis – Strengthening global sourcing resilience amid geopolitical and supply‑chain disruption\nRegeneron Pharmaceuticals – Optimising supplier governance and long‑term strategic partnerships\nVertex Pharmaceuticals – Integrating data\, technology and AI to streamline R&D procurement operations\nTakeda & UCB – Elevating procurement’s influence through early‑stage R&D decision‑making\n\nWhy Attend? \n\nThree days of immersive learning across discovery\, pre‑clinical and clinical procurement tracks\n30+ expert speakers sharing real‑world case studies and practical\, execution‑ready frameworks\nDedicated sessions on AI‑enabled procurement\, supplier relationship management and global sourcing resilience\nExtensive networking opportunities with peers shaping the future of R&D procurement and sourcing\n\nJoin us in Boston to help redefine procurement as a strategic engine for R&D innovation\, delivering speed\, resilience and measurable supplier value across the development pipeline.
URL:https://www.pharmajournalist.com/event/10th-rd-procurement-sourcing-in-pharma-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR